Bristol-Myers Squibb
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BMY and other ETFs, options, and stocks.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
BMY News
Loading... Loading... 4 analysts have expressed a variety of opinions on Bristol-Myers Squibb BMY over the past quarter, offering a diverse set of opinions fro...
Pavel Muravev/iStock via Getty Images Investment Overview Bristol-Myers Squibb (NYSE:BMY) has provided a mixed set of Q1 2024 quarterly earnings today, which...
Pharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug patents to expire in the next few years. Both companies reported...
Analyst ratings
71%
of 28 ratingsMore BMY News
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions Thursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter r...
Normally, planned layoffs are a good thing for a stock. Shares go up as companies cut costs and demonstrate they have the fortitude to make the tough calls. Whi...
Bristol-Myers Squibb Company BMY reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.53 per share. In the y...
Bristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now arguably no longer part of the big pharma club. After reporti...
With its Q1 2024 results on Thursday, Bristol-Myers Squibb (NYSE:BMY) announced plans to lay off 2,200 employees this year as part of a cost-cutting initiative...
Revenue: Reported at $11.9 billion, up 5% year-over-year, exceeding the estimate of $11.457 billion. Net Loss: Reported a GAAP net loss of $11.9 billion, signi...
Bristol-Myers Squibb (BMY) has shared an announcement. Bristol Myers Squibb has shared a presentation detailing its financial and operational strategies during...